This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Sickle cell disease is very variable in its outlook. In rural parts of Africa children rarely survive beyond the first year. On the other hand in developed Western countries many patients with sickle cell anaemia survive well into adult life. The commonest cause of death is infection.

Previously stated mortality was (1):

In the USA the median life expectancy in HbSS is:

  • 42 for men
  • 48 for women

In the USA the median life expectancy in HbSC is:

  • 60 for men
  • 68 for women

Factors which modify the condition are elevated levels of fetal haemoglobin and the co-existence of thalassaemia. For example, in India and parts of Eastern Saudi Arabia patients are often asymptomatic with sickle cell anaemia because they produce very high levels of foetal haemoglobin.

Most deaths from this condition occur in the second six months of life.

Notes:

  • mortality and morbidity rates in sickle cell disease (SCD) have been considerably reduced since the introduction of hydroxyurea (HU) in the 1990s (2)
    • an update of the Multicenter Study of Hydroxyurea (MSH) showed that at 9 years' follow-up, the mortality rate among patients who take HU is reduced 40% compared with the rate among patients who do not take the drug
  • a study was undertaken to evaluate the pattern of medical care utilization and mortality in children and adults with sickle cell disease (SCD) in the state of Tennessee (3)
    • rates of hospitalization, emergency department visits, and deaths were measured in a cohort of adults and children with SCD enrolled in TennCare, Tennessee's Medicaid managed health care program, from January 1995 to December 2002
    • for children less than 5 years of age, the mortality rate was similar to that of other black Tennessee children (P = 0.71). Among children, the death rate was highest in 10-19 years of age and was 8-fold higher than Tennessee's race- and age-specific rate
    • among 20- to 49-year-old patients with SCD, mortality was significantly higher in males than in females (P < 0.001)
    • as compared to the black population without SCD in TennCare, patients with SCD had 7-30 times higher rate of hospitalization and 2-6 times higher rates of emergency department visits (P < 0.001
    • death rates among children 10-19 years old with SCD are higher than those among children<5 years of age

Reference:

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.